Aster Capital Management’s Tarsus Pharmaceuticals TARS Stock Holding History
Bought
Maintained
Sold
Other funds holding TARS
Aster Capital Management's TARS Position: Q3 2026 in Review
Aster Capital Management increased its Tarsus Pharmaceuticals (TARS) stake by 42% in Q3 2026, buying an estimated $3.47K and bringing the position to 170 shares worth $13.4K. The position accounts for ﹤0.01% of the portfolio, ranked #743.
Aster Capital Management first reported a position in TARS in Q4 2024 and has held it in 3 quarters since. 255 funds tracked by Wall St. Rank hold TARS as of Q3 2026.
- Aster Capital Management held 170 shares of Tarsus Pharmaceuticals worth $13.4K as of Q3 2026.
- Aster Capital Management bought 50 Tarsus Pharmaceuticals shares in Q3 2026, an estimated $3.47K.
- Tarsus Pharmaceuticals made up ﹤0.01% of Aster Capital Management's portfolio in Q3 2026, its #743 holding.
- Aster Capital Management first reported a position in Tarsus Pharmaceuticals in Q4 2024 and has held it in 3 quarters since.
- 255 funds tracked by Wall St. Rank held Tarsus Pharmaceuticals as of Q3 2026.
Based on Aster Capital Management's 13F filing for Q3 2026, filed 12 Nov 2026.